CooperSurgical (COO) - Long-Term Liabilities to Capital

The current share price of The Cooper Companies (COO) shown on this chart is based on stable demand for innovative optics and women's health devices, where the indicator stands at 0.24. The Cooper Companies (COO) dominates an oligopolistic lens sector protected from new entrants by years of testing. Stringent patent controls and regulatory requirements make expansion by third-party manufacturers virtually impossible, cementing the brand's leadership.

The steady stream of recurring payments from The Cooper Companies (COO) lens users enables the efficient servicing of borrowed funds. By analyzing the current long-term debt-to-equity ratio, an investor assesses the proportion of liabilities exceeding one year within the financing structure relative to equity, which helps determine the balance between financial leverage and the company's risk profile compared to US industry standards.